|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.15 USD | -2.80% |
|
-2.96% | -35.82% |
| 16/05 | Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
| 09/05 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
Embecta Corp. reported earnings results for the full year ended September 30, 2023. For the full year, the company reported sales was USD 1,120.8 million compared to USD 1,129.5 million a year ago.
Net income was USD 70.4 million compared to USD 223.6 million a year ago. Basic earnings per share from continuing operations was USD 1.23 compared to USD 3.92 a year ago. Diluted earnings per share from continuing operations was USD 1.22 compared to USD 3.89 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -35.82% | 721M | |
| -6.24% | 181B | |
| -6.39% | 101B | |
| -5.97% | 67.54B | |
| -9.61% | 45.09B | |
| +8.84% | 44.37B | |
| +5.36% | 40.7B | |
| +12.69% | 29.85B | |
| +10.26% | 24.49B | |
| -7.83% | 23.99B |
EMBECTA CORP. 
